FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients - TCTMD

Reuters UK

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients TCTMD In a move that extends TAVR to patients with aortic valve stenosis who are less than high risk for surgery, the US Food and Drug Administration (FDA) today approved expanded indications for the Sapien XT and Sapien 3 transcatheter heart valves (Edwards ... FDA approves expanded indication for two transcatheter heart valves for patients at intermediate risk for death or ...FDA.gov all 11 news articles »

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients - TCTMD
Read More